Financial Management Network Inc. Lowers Stock Holdings in Axon Enterprise, Inc $AXON

Financial Management Network Inc. reduced its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 45.5% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 300 shares of the biotechnology company’s stock after selling 250 shares during the quarter. Financial Management Network Inc.’s holdings in Axon Enterprise were worth $239,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. TCTC Holdings LLC lifted its holdings in shares of Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after buying an additional 24 shares during the period. Fourth Dimension Wealth LLC acquired a new stake in shares of Axon Enterprise in the 4th quarter valued at approximately $30,000. Bartlett & CO. Wealth Management LLC lifted its holdings in shares of Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after buying an additional 33 shares during the period. Banque Transatlantique SA acquired a new stake in shares of Axon Enterprise in the 1st quarter valued at approximately $31,000. Finally, Catalyst Capital Advisors LLC acquired a new stake in shares of Axon Enterprise in the 1st quarter valued at approximately $32,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CAO Jennifer H. Mak sold 77 shares of Axon Enterprise stock in a transaction on Monday, September 15th. The stock was sold at an average price of $760.00, for a total value of $58,520.00. Following the completion of the sale, the chief accounting officer owned 15,003 shares of the company’s stock, valued at $11,402,280. The trade was a 0.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the completion of the sale, the president directly owned 238,379 shares of the company’s stock, valued at approximately $177,892,712.54. This represents a 6.26% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 44,932 shares of company stock valued at $34,408,816. 4.40% of the stock is currently owned by company insiders.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $751.81 on Thursday. The company has a market cap of $59.02 billion, a P/E ratio of 185.63, a P/E/G ratio of 27.55 and a beta of 1.40. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 52 week low of $380.51 and a 52 week high of $885.91. The business has a fifty day simple moving average of $758.40 and a 200-day simple moving average of $690.85.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. The business had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business’s revenue for the quarter was up 32.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Equities research analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have recently commented on AXON shares. Wolfe Research started coverage on Axon Enterprise in a report on Monday, July 7th. They issued an “outperform” rating for the company. Morgan Stanley set a $885.00 price target on Axon Enterprise and gave the company an “overweight” rating in a report on Friday, July 11th. Craig Hallum raised Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price target for the company in a report on Tuesday, August 5th. JPMorgan Chase & Co. lifted their price objective on Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a report on Thursday, July 17th. Finally, Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $837.69.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.